Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Conditions:   Acute Respiratory Failure;   SARS CoV 2 Infection;   Anticoagulants Interventions:   Drug: Enoxaparin Sodium;   Drug: Bivalirudin Sponsor:   University Magna Graecia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials